Next Generation Dx Summit
  • Final Agenda Now Available
  • About the Summit
  • Slide 3
  • Record Attendance Expected

Concurrent Programs


Short Courses - View Details 


About the Summit

Access to next generation diagnostics will only be gained through careful creation and management of partnerships in the community around development, commercialization, reimbursement and regulation. This year’s Next Generation Dx Summit will showcase advances in personalized medicine through a comprehensive program encompassing companion diagnostics, infectious disease, cancer molecular markers, point-of-care, inherited disorders, cell-free DNA and single-cell sequencing.

This event has become the meeting place for major players in the expanding arena of diagnostics. It will showcase key components of their successful adoption in the clinic and advancement to the market. Please join the leaders in the community for another exceptional year.

Attendee Testimonials

"The Next Generation Dx Summit brings together key players from all facets of diagnostic development. Its format is very conducive to networking and learning from the leaders in the field. This is a great meeting for anyone who is serious about pursing diagnostic technologies anywhere from research to commercialization."
Program Director, Fluxion Biosciences

"The meeting was excellent, one of the best I have attended, and the standard of talks matched to the schedule across the board."
Vice President, Diagnostics, GlaxoSmithKline

 "As we begin to move from a centralized lab to a point-of-care setting we have faced many challenges. It has been a very rewarding meeting with the leaders in policy making along with the leaders in development all in the same place."
Pathology, Graves Gilbert Clinic

"Great conference! Most up to date data. Perfect amalgamation between industry, labs, clinicians and regulatory bodies. Highly recommended!"
Clinical Microbiology Fellow, NIH

View More Attendee Quotes 

PLENARY SESSION:

Think Tank on Next-Generation Sequencing Diagnostics 

Discussion: Regulatory Review of Clinical Sequencing Assays 

Harry GlorikianModerator: Harry Glorikian, Healthcare Consultant

 

Jennifer DickeyGuest Speaker: Jennifer Dickey, RAC, Ph.D., Office of In Vitro Diagnostics, DIHD, US Food and Drug Administration

 

Next-Generation Sequencing in Clinical Practice: Case Reports of Clinical Utility and Reimbursement
Co-Organized with AMP 

Elaine LyonModerator: Elaine Lyon, Ph.D., Medical Director, Molecular Genetics, ARUP

 

Case Presenters:
Andrea Ferreira-GonzalezAndrea Ferreira-Gonzalez, Ph.D., Professor, Pathology; Director, Molecular Diagnostics Lab, Virginia Commonwealth University

 

Madhuri HegdeMadhuri Hegde, Ph.D., FACMG, Associate Professor, Human Genetics; Executive Director, Emory Genetics Laboratory, Emory University School of Medicine

 
 
 

Event Features

  • Meet all the major players in the evolving areas of diagnostics
  • Get a comprehensive view of the changing landscape of diagnostics
  • Network with 700+ global attendees
  • Interactive Regulatory Session on Multiplex Sequencing Assays
  • Connect with attendees using CHI’s Intro-Net
  • Participate in the poster competition
  • Choose from 10 short courses
  • View innovative products and novel technologies in the expansive exhibit hall
  • And much more!
 
 

Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag 


2014 Brochure 


Premier Sponsors

Affymetrix 

Luminex 

Certara 



MDX_Logo_150x150